adverse events
Sarepta Pauses EU Elevidys Trials, Data Monitoring Panel Confirms Favorable Risk-Benefit Profile
The firm said the clinical trial pause is temporary as an independent data monitoring committee finalizes its analysis for submission to regulators.
NCCN Updates Colorectal Cancer Guidelines Advising Docs to Discuss DPYD Testing With Patients
Although the guidelines body still doesn't back routine DPYD testing prior to starting chemo, patient advocates say it's a step in the right direction.
Patient Dies After Treatment With Sarepta's Duchenne Muscular Dystrophy Gene Therapy
The firm's stock price dropped 27 percent on Tuesday following the news that the young man died from acute liver failure after getting Elevidys.
Indonesia to Kick off PGx Program for Leprosy Patients With Singapore's NalaGenetics
The program will use NalaGenetics' PGx test to screen leprosy patients for the HLA-B*13:01 allele, which has been linked with a serious hypersensitivity reaction.
FDA Issues Safety Alert Reminding Doctors to Discuss DPD Deficiency Risk With Cancer Patients
The FDA, which has stopped short of requiring DPYD testing for patients before receiving fluoropyrimidines, emphasized the importance of discussing it.